ThermoGenesis launches cell processing system for cell therapies

By The Science Advisory Board staff writers

ThermoGenesis has completed the development process for its PXP-Lavare system for automated cell processing. The company has submitted a letter to file and updated the device listing with the U.S. Food and Drug Administration (FDA).

PXP-Lavare is a good manufacturing practice (GMP) compliant system that allows for fast, automated, and reliable washing and reformation of cell suspension. Its optional cell reformation accessory is designed for use with the PXP-1000 system, an FDA-cleared medical device that is used for downstream current GMP-compliant clinical manufacturing of cell-based therapeutics.

The completed closed system includes the control module, docking station, disposable cartridge, and DataTRAK software, which captures sample processing data to assist with quality assurance and compliance with current GMP practices.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking